Atlantic Healthcare and AcedrA BioPharmaceuticals sign MOU to explore commercial opportunities in the Middle East
Cambridge, UK; 15th July, 2020. Atlantic Healthcare plc (“Atlantic Healthcare”…
Atlantic Healthcare joins the panel at Virtual 2020 BMG Economic Forum, 15th July
Cambridge, UK; 10th July, 2020. We are delighted to announce that Toby Wilson…
The COVID-19 virus pandemic highlights the need for a step change in the treatment of moderate to severe Inflammatory Bowel Disease
• COVID-19 virus highlights medical need to move beyond immunosuppression…
Atlantic Healthcare supports World IBD Day
Cambridge, UK; May 19, 2020. Atlantic Healthcare plc (“Atlantic Healthcare” or…
Atlantic Healthcare appoints finance industry veteran Andrew Jones to Board of Directors
Cambridge, UK; February 19, 2020. Atlantic Healthcare plc (“Atlantic…
Atlantic Healthcare Hosts Key Opinion Leader Discussion on Unmet Medical Need in Ulcerative Colitis and the Advantages of Alicaforsen
Cambridge, UK; 31 January 2020 – Atlantic Healthcare plc (“Atlantic Healthcare”…
Atlantic Healthcare to present at JPM / Biotech Showcase 13-15 January 2020, San Francisco, USA
Cambridge, UK; 17 December 2019. Atlantic Healthcare plc (“Atlantic Healthcare”…
Atlantic Healthcare Announces Results from Phase 3 Trial of Alicaforsen Enema for Orphan-Designated Pouchitis
Cambridge, UK; July 31, 2019. Atlantic Healthcare plc (“Atlantic Healthcare” or…
Atlantic Healthcare plc acquires global rights to renzapride for the treatment of gastrointestinal motility disorders
Cambridge, UK; June 26, 2019. Atlantic Healthcare plc (“Atlantic Healthcare” or…
Atlantic Healthcare to attend DDW in San Diego, May 18-21
Cambridge, UK; May 1, 2019. Atlantic Healthcare plc (“Atlantic Healthcare” or…
